GBA1
Lysosomal acid glucosylceramidase
Also known as: GBA, GBA1_HUMAN, GLUC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04062
- Gene
- GBA1
- Ensembl
- ENSG00000177628
- Chromosome
- 1
- Canonical length
- 536 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
536 residues, UniProt reviewed canonical sequence.
>P04062|GBA1
1 MEFSSPSREE CPKPLSRVSI MAGSLTGLLL LQAVSWASGA RPCIPKSFGY SSVVCVCNAT
61 YCDSFDPPTF PALGTFSRYE STRSGRRMEL SMGPIQANHT GTGLLLTLQP EQKFQKVKGF
121 GGAMTDAAAL NILALSPPAQ NLLLKSYFSE EGIGYNIIRV PMASCDFSIR TYTYADTPDD
181 FQLHNFSLPE EDTKLKIPLI HRALQLAQRP VSLLASPWTS PTWLKTNGAV NGKGSLKGQP
241 GDIYHQTWAR YFVKFLDAYA EHKLQFWAVT AENEPSAGLL SGYPFQCLGF TPEHQRDFIA
301 RDLGPTLANS THHNVRLLML DDQRLLLPHW AKVVLTDPEA AKYVHGIAVH WYLDFLAPAK
361 ATLGETHRLF PNTMLFASEA CVGSKFWEQS VRLGSWDRGM QYSHSIITNL LYHVVGWTDW
421 NLALNPEGGP NWVRNFVDSP IIVDITKDTF YKQPMFYHLG HFSKFIPEGS QRVGLVASQK
481 NDLDAVALMH PDGSAVVVVL NRSSKDVPLT IKDPAVGFLE TISPGYSIHT YLWRRQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GBA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 98 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 98 nTPM
- choroid plexus: 55 nTPM
- epididymis: 48 nTPM
- pituitary gland: 41 nTPM
- bone marrow: 40 nTPM
- rectum: 38 nTPM
Single-cell type
- syncytiotrophoblasts: 19 nCPM
- esophageal apical cells: 18 nCPM
- proximal tubule cells: 16 nCPM
- podocytes: 13 nCPM
- loop of henle epithelial cells: 11 nCPM
- distal convoluted tubule cells: 9.7 nCPM
Immune cell
- non-classical monocyte: 38 nTPM
- classical monocyte: 36 nTPM
- intermediate monocyte: 36 nTPM
- neutrophil: 30 nTPM
- T-reg: 24 nTPM
- total PBMC: 23 nTPM
Brain region
- pons: 61 nTPM
- thalamus: 48 nTPM
- white matter: 45 nTPM
- midbrain: 44 nTPM
- medulla oblongata: 43 nTPM
- hypothalamus: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GBA1.
Disease | AllUniProt
Conditions GBA1 is implicated in, by any mechanism.
- Gaucher disease (GD) MIM:230800
- Gaucher disease 1 (GD1) MIM:230800
- Gaucher disease 2 (GD2) MIM:230900
- Gaucher disease 3 (GD3) MIM:231000
- Gaucher disease 3C (GD3C) MIM:231005
- Gaucher disease perinatal lethal (GDPL) MIM:608013
- Parkinson disease (PARK) MIM:168600
Disease | GeneticClinVar
364 pathogenic / likely-pathogenic of 752 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Gaucher disease
- Gaucher disease type I
- Gaucher disease type II
- Gaucher disease type III
- 7 conditions
Disease | ImmuneIEDB
Conditions an epitope on GBA1 was assayed in.
- Parkinson's disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antigen processing and presentation
- autophagosome organization
- autophagy
- beta-glucoside catabolic process
- brain morphogenesis
- cell maturation
- cellular response to starvation
- cellular response to tumor necrosis factor
- ceramide biosynthetic process
- cerebellar Purkinje cell layer formation
- cholesterol metabolic process
- determination of adult lifespan
- establishment of skin barrier
- glucosylceramide catabolic process
- glycolipid biosynthetic process
- hematopoietic stem cell proliferation
- homeostasis of number of cells
- immune response
- lipid storage
- lymphocyte migration
- lysosomal protein catabolic process
- lysosome organization
- microglia differentiation
- microglial cell proliferation
- mitophagy
- motor behavior
- negative regulation of inflammatory response
- negative regulation of interleukin-6 production
- negative regulation of MAPK cascade
- negative regulation of neuron apoptotic process
- negative regulation of protein metabolic process
- negative regulation of protein-containing complex assembly
- neuromuscular process
- neuron apoptotic process
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of type 2 mitophagy
- proteasome-mediated ubiquitin-dependent protein catabolic process
- pyramidal neuron differentiation
- regulation of lysosomal protein catabolic process
- regulation of macroautophagy
- regulation of TOR signaling
- respiratory electron transport chain
- response to dexamethasone
- response to estrogen
- response to pH
- response to testosterone
- response to thyroid hormone
- sphingosine biosynthetic process
- T cell differentiation in thymus
- termination of signal transduction
- thymus development
- positive regulation of neuronal action potential
Molecular functions
- beta-glucosidase activity
- galactosylceramidase activity
- glucosylceramidase activity
- glucosyltransferase activity
- scavenger receptor binding
- signaling receptor binding
- steryl-beta-glucosidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycoside hydrolase superfamily
- Glycoside hydrolase family 30
- Glycosyl hydrolase family 30, beta sandwich domain
- Glycosyl hydrolase family 30, TIM-barrel domain
- Glycosyl hydrolase family 30 TIM-barrel domain
- Glycosyl hydrolase family 30 beta sandwich domain
KeywordsUniProt
- Alternative initiation
- Cholesterol metabolism
- Disulfide bond
- Gaucher disease
- Glycoprotein
- Glycosidase
- Glycosyltransferase
- Hydrolase
- Ichthyosis
- Lipid metabolism
- Lysosome
- Membrane
- Neurodegeneration
- Parkinson disease
- Parkinsonism
- Pharmaceutical
- Signal
- Sphingolipid metabolism
- Steroid metabolism
- Sterol metabolism
- Transferase
InteractionsUniProt · HPA
Protein binding partners of GBA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GBA1 as an antibody target. Whether an autoantibody or antibody against GBA1 could matter depends on whether native GBA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GBA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GBA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...